1. 68 Ga Radiolabeling of NODASA-Functionalized Phage Display-Derived Peptides for Prospective Assessment as Tuberculosis-Specific PET Radiotracers.
- Author
-
Gouws CA, Naicker T, de la Torre BG, Albericio F, Duvenhage J, Kruger HG, Marjanovic-Painter B, Mdanda S, Zeevaart JR, Ebenhan T, and Govender T
- Subjects
- Animals, Isotope Labeling, Radiopharmaceuticals chemical synthesis, Radiopharmaceuticals chemistry, Mycobacterium tuberculosis, Tuberculosis diagnostic imaging, Mice, Peptides chemistry, Tissue Distribution, Peptide Library, Heterocyclic Compounds, 1-Ring chemistry, Acetates, Gallium Radioisotopes chemistry, Positron-Emission Tomography methods
- Abstract
This research presents the development of positron emission tomography (PET) radiotracers for detecting Mycobacterium tuberculosis (MTB) for the diagnosis and monitoring of tuberculosis. Two phage display-derived peptides with proven selective binding to MTB were identified for development into PET radiopharmaceuticals: H8 (linear peptide) and PH1 (cyclic peptide). We sought to functionalize H8/PH1 with NODASA, a bifunctional chelator that allows complexation of PET-compatible radiometals such as gallium-68. Herein, we report on the chelator functionalization, optimized radiosynthesis, and assessment of the radiopharmaceutical properties of [
68 Ga]Ga-NODASA-H8 and [68 Ga]Ga-NODASA-PH1. Robust radiolabeling was achieved using the established routine method, indicating consistent production of a radiochemically pure product (RCP ≥ 99.6%). For respective [68 Ga]Ga-NODASA-H8 and [68 Ga]Ga-NODASA-PH1, relatively high levels of decay-corrected radiochemical yield (91.2% ± 2.3%, 86.7% ± 4.0%) and apparent molar activity (Am , 3.9 ± 0.8 and 34.0 ± 5.3 GBq/μmol) were reliably achieved within 42 min, suitable for imaging purposes. Notably, [68 Ga]Ga-NODASA-PH1 remained stable in blood plasma for up to 2 h, while [68 Ga]Ga-NODASA-H8 degraded within 30 min. For both68 Ga peptides, minimal whole-blood cell binding and plasma protein binding were observed, indicating a favorable pharmaceutical behavior. [68 Ga]Ga-NODASA-PH1 is a promising candidate for further in vitro/in vivo evaluation as a tuberculosis-specific infection imaging agent., (© 2024 The Author(s). Journal of Labelled Compounds and Radiopharmaceuticals published by John Wiley & Sons Ltd.)- Published
- 2024
- Full Text
- View/download PDF